Abstract
Vasoactive intestinal peptide (VIP) is found within neurons throughout the body. It influences the secretion of several hormones of the anterior pituitary by neural and pituitary actions. We review work from our laboratory that indicates that VIP inhibits the secretion of luteinizing hormone (LH) by a hypothalamic action. Experiments involving neural lesions indicate that VIP acts on the receptor field in the paraventricular nuclei of neurons whose cell bodies are located in the suprachiasmatic nuclei. The effect on LH secretion is subsequently mediated by a nonVIPergic pathway, which does not appear to involve either dopamine or endogenous opioids. Experiments with the specific VIP antagonist, [4Cl- D-Phe 6,Leu 17]VIP, indicate that the actions on LH secretion of VIP and of the related peptides, growth hormone-releasing hormone and secretin, are mediated by VIP-preferring receptors. VIP also blocks the steroid-induced LH surge in the ovariectomized rat. The VIP antagonist induces a significant, but small increase in LH secretion in the intact rat, indicating that VIP has a modulatory, rather than deterministic, role in the regulation of LH secretion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
